Found 18 matching trials
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies PHASE2 In this study the investigators investigate a cell therapy strategy that co...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors EARLY_PHASE1 Background:
The presence of T-lymphocytes in resected tumor samples derive...
Show More Location
Vall d'Hebron Institute of Oncology
Learn More & Join Trial
TIL-ACT After NMA Chemo with IL-2 and Nivo Rescue in Metastatic Melanoma (mMEL) PHASE1 This is a single center, single arm phase I trial to test the feasibility a...
Show More Location
CHUV Oncology Department
Learn More & Join Trial
NeoTIL in Advanced Solid Tumors PHASE1 Single center, single arm pilot trial to test the feasibility, safety and e...
Show More Status
Active Not Recruiting
Location
centre hospitalier universitaire vaudois (CHUV)
Learn More & Join Trial
TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients PHASE2 Aim of the study is to investigate the efficacy and safety of adoptive cell...
Show More Location
Department of Medical Oncology, University Hospital Basel
Learn More & Join Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma PHASE2 Background:
\- The National Cancer Institute (NCI) Surgery Branch has deve...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors PHASE1 Single center, single arm phase Ib trial to test the feasibility and safety...
Show More Location
CHUV Oncology Department
Learn More & Join Trial
Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... PHASE2 Background:
\- An experimental treatment for metastatic melanoma involves ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial